To further strengthen its foothold in China, BaselArea.swiss opened a branch office at the newly established Fenglin Biomedical Center in Shanghai. The office, led by Chief Representative China Mr. GAO Ronghui, will help BaselArea.swiss to promote the Basel region as a prime Life Sciences location and to support Chinese companies interested in expanding their business to Europe.
The Fenglin Life Sciences Park, located in Shanghai’s Xuhui District, is the birthplace of China’s Life Sciences research and one of Shanghai’s two main biomedical industry zones. The area has the China’s highest concentration of leading hospitals, universities and biomedical research institutes. Many multinational companies and local biomedical companies, such as Johnson & Johnson, Hisun-Pfizer, MSD, Shanghai Pharmaceutical Group and Yangzi River Pharmaceutical Group are based there.
The newly created Fenglin Biomedical Center serves as a soft-landing platform for small and medium-sized Life Sciences companies from China and abroad. On September 20th, 2017 BaselArea.swiss’s Senior Project Manager Asia, Gabriel Schweizer, took part in the grand opening ceremony of the Fenglin Biomedical Center to officially announce the new Shanghai office.